CliffBio
small molecule

SHADE UVAGUARD

AVOBENZONE; OCTINOXATE; OXYBENZONE

Loss of exclusivity—loss of exclusivity
CompanyBayer Healthcare →See this company's full patent-cliff portfolio

Drug detail

Brand nameSHADE UVAGUARD
Active ingredientAVOBENZONE; OCTINOXATE; OXYBENZONE
Strength3%;7.5%;3%
Dosage formLOTION
RouteTOPICAL
ModalitySmall molecule
FDA approvalDecember 1992
Marketing statusDISCN

More from Bayer Healthcare

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.